Topic: Coronavirus Patent

Dr. David Martin traces the history of coronavirus research back to 1965, noting that Pfizer filed its first coronavirus vaccine patent in 1990. He details how Ralph Baric modified the virus in the late 1990s to specifically target heart tissue, leading to cardiomyopathy in test subjects. Martin asserts that the myocarditis and blood clots observed after COVID-19 vaccinations were not unintended side effects but known outcomes of the engineered spike protein technology.

In a recorded presentation, Dr. David Martin details the history of coronavirus research dating back to 1965. He reveals that Pfizer filed the first patent for a coronavirus spike protein vaccine in 1990 for use in dogs and pigs. Martin argues that the scientific community has known since 1990 that coronaviruses mutate too quickly for vaccines to be effective.

Dr. Zelenko reveals research showing that Dr. Ralph Baric was involved in every step of developing the COVID-19 bioweapon, funded by the NIH. He points out the irony that Baric also published papers in 2010 on using zinc to inhibit coronavirus replication. Zelenko argues that the "antidote" to the virus was known and suppressed by the same people who engineered the pathogen.